An under-recognised risk

Osteoporosis is another important but under-recognised risk of androgen deprivation therapy.1 Few guidelines exist to help detect and manage bone loss in these men. As survival from prostate cancer increases, osteoporosis and its complications will probably become more common. A retrospective study of over 50 000 men with prostate cancer …